Changeflow GovPing Healthcare & Life Sciences Ortho Vision Max Immuno-Hematology Device Safet...
Priority review Guidance Added Final

Ortho Vision Max Immuno-Hematology Device Safety Alert

Favicon for ansm.sante.fr ANSM Drug & Device Safety Alerts
Published
Detected
Email

Summary

ANSM issued a safety information notice (Ref. R2608831) regarding a safety action by QuidelOrtho for Ortho Vision Max and Ortho Vision automated immuno-hematology analyzers. Medical analysis laboratories using these devices have received direct correspondence from the manufacturer about the safety measure. Users with questions should contact QuidelOrtho directly.

Published by ANSM on ansm.sante.fr . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

ANSM informed medical biology laboratories of a safety action conducted by QuidelOrtho for their Ortho Vision Max and Ortho Vision automated immuno-hematology analyzers. The safety action is registered under reference number R2608831. A PDF letter from QuidelOrtho dated 01/04/2026 accompanies this notice.

Laboratories using Ortho Vision Max or Ortho Vision devices should review the manufacturer's safety communication and follow any instructions provided. Questions regarding the specific safety measure should be directed to QuidelOrtho as the issuer of the action. ANSM serves as a notifying authority in this instance rather than the primary source of safety instructions.

What to do next

  1. Review the QuidelOrtho safety letter for Ortho Vision Max and Ortho Vision analyzers
  2. Follow any instructions or corrective actions specified in the manufacturer's communication
  3. Direct questions about this safety action to QuidelOrtho directly

Archived snapshot

Apr 1, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

A+ A-

Information n° R2608831 destinée aux laboratoires d'analyses de biologie médicale L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société Quidelortho.

Les utilisateurs concernés ont reçu le courrier ci-joint.

Cette action de sécurité est enregistrée à l’ANSM sous le n° R2608831. Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Téléchargez le courrier de la société Quidelortho (01/04/2026)

Named provisions

Immuno-hématologie - Automates Ortho Vision Max / Ortho Vision - QuidelOrtho

Get daily alerts for ANSM Drug & Device Safety Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from ANSM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
ANSM
Published
April 1st, 2026
Instrument
Guidance
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
R2608831

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
6211 Healthcare Providers 3345 Medical Device Manufacturing
Activity scope
Medical Device Safety Reporting Immuno-Hematology Testing
Geographic scope
France FR

Taxonomy

Primary area
Medical Devices
Operational domain
Compliance
Topics
Healthcare Public Health

Get alerts for this source

We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!